Tuesday, February 10, 2015
Scynexis to get new CEO
Durham drug developer Scynexis has named Dr. Marco Taglietti as CEO to replace Yves Ribeill, who ran the company for 15 years. Ribeill will remain the company's president and continue to serve on the board of directors.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment